Identifying Biomarkers of Lung Cancer in the Post-Genomic Era

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|3|4|319-331

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.3, Iss.4, 2005-12, pp. : 319-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic targets in tuberculosis: post-genomic era

By Khasnobis Shampa   Escuyer Vincent E   Chatterjee Delphi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite

Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era

By  

Current Molecular Pharmacology, Vol. 7, Iss. 1, 2014-04 ,pp. : 33-43

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Applications of the Post Genomic Era

By  

Current Pharmaceutical Biotechnology, Vol. 3, Iss. 2, 2002-01 ,pp. : 141-150

Bentham Science Publishers

Access to resources Recommend Favorite

Familial Mediterranean Fever in the Post-Genomic Era: How an Ancient Disease is Providing New Insights into Inflammatory Pathways

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 67-76

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Genomic Design of Bioactive Molecules

By  

Current Computer - Aided Drug Design, Vol. 1, Iss. 2, 2005-04 ,pp. : 147-162

Bentham Science Publishers

Access to resources Recommend Favorite